(Corrects to show delays due to internal controls, not regulatory delays)
MEXICO CITY (Reuters) – AstraZeneca has confirmed setbacks to production of its COVID-19 vaccines in Latin America, excluding Brazil, but said it will still meet a commitment to deliver 150 million doses to the region this year.
The Anglo-Swedish drugmaker said in a statement shared with Reuters on Friday that lower-than-expected production, shortages of critical supplies and longer periods to meet internal controls had slowed the process.
(Reporting by Adriana Barrera; Writing by Stefanie Eschenbacher; Editing by Frank Jack Daniel)
